Abstract Repeated cystoscopy for non-muscle-invasive bladder cancer incurs costs and greenhouse-gas emissions, but fewer examinations may delay recurrence detection. We compared nine surveillance schedules in a 15-year monthly cohort model stratified by European Association of Urology risk group. We used 2021 United States costs and an international emissions inventory.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile